Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2006 4
2007 3
2008 5
2009 5
2010 2
2011 4
2012 4
2013 1
2014 5
2015 3
2016 1
2017 1
2018 2
2019 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.
Versteven M, Van den Bergh JMJ, Broos K, Fujiki F, Campillo-Davo D, De Reu H, Morimoto S, Lecocq Q, Keyaerts M, Berneman Z, Sugiyama H, Van Tendeloo VFI, Breckpot K, Lion E. Versteven M, et al. Among authors: van tendeloo vfi. Oncotarget. 2018 Jun 12;9(45):27797-27808. doi: 10.18632/oncotarget.25591. eCollection 2018 Jun 12. Oncotarget. 2018. PMID: 29963238 Free PMC article.
The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells.
Willemen Y, Van den Bergh JM, Bonte SM, Anguille S, Heirman C, Stein BM, Goossens H, Kerre T, Thielemans K, Peeters M, Van Tendeloo VF, Smits EL, Berneman ZN. Willemen Y, et al. Among authors: van tendeloo vf. Oncotarget. 2016 Nov 8;7(45):73960-73970. doi: 10.18632/oncotarget.12170. Oncotarget. 2016. PMID: 27659531 Free PMC article.
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.
Willemen Y, Van den Bergh JM, Lion E, Anguille S, Roelandts VA, Van Acker HH, Heynderickx SD, Stein BM, Peeters M, Figdor CG, Van Tendeloo VF, de Vries IJ, Adema GJ, Berneman ZN, Smits EL. Willemen Y, et al. Among authors: van tendeloo vf. Cancer Immunol Immunother. 2015 Jul;64(7):831-42. doi: 10.1007/s00262-015-1688-2. Epub 2015 Apr 12. Cancer Immunol Immunother. 2015. PMID: 25863943 Free PMC article.
Interleukin-15: new kid on the block for antitumor combination therapy.
Van den Bergh JM, Van Tendeloo VF, Smits EL. Van den Bergh JM, et al. Among authors: van tendeloo vf. Cytokine Growth Factor Rev. 2015 Feb;26(1):15-24. doi: 10.1016/j.cytogfr.2014.09.001. Epub 2014 Sep 28. Cytokine Growth Factor Rev. 2015. PMID: 25306466
Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells.
Van Craenenbroeck AH, Smits EL, Anguille S, Van de Velde A, Stein B, Braeckman T, Van Camp K, Nijs G, Ieven M, Goossens H, Berneman ZN, Van Tendeloo VF, Verpooten GA, Van Damme P, Cools N. Van Craenenbroeck AH, et al. Among authors: van tendeloo vf. Transplantation. 2015 Jan;99(1):120-7. doi: 10.1097/TP.0000000000000272. Transplantation. 2015. PMID: 25050468 Free PMC article. Clinical Trial.
42 results